Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives

Antiviral Research

Volumn 59, Issue 3, 2003, Pages 143-154

  Lowden, C T ^a,b   Bastow, K F ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b PDD Development   (United States)

Author keywords

Acridone; Antiviral; Citrus alkaloids; HCMV; HSV; Parallel synthesis

Indexed keywords

1 HYDROXY 3 ISOPROPOXY 7 METHOXYACRIDONE; 3 ALLYLOXY 1 HYDROXY 7 METHOXYACRIDONE; 3 ETHOXY 1 HYDROXY 7 METHOXYACRIDONE; 3,7 DIMETHOXY 1 HYDROXYACRIDONE; ACRIDONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL DIVISION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG POTENCY; HERPES SIMPLEX VIRUS; HOST CELL; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

CITRUS; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; SIMPLEXVIRUS;

EID: 0041631012     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00106-2     Document Type: Article

References (24)

1. Akanitapichat P., Lowden C.T., Bastow K.F. 1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication. Antiviral Res. 45:2000;123-134.
2. Akanitapichat P., Bastow K.F. The antiviral agent 5-chloro-1,3-dihydroxyacridone interferes with assembly and maturation of herpes simplex virus. Antiviral Res. 53:2002;113-126.
3. Bastow K.F., Itogawa M., Furokawa H., Kashiwada Y., Bori I.D., Ballas L.M., Lee K.-H. Antiproliferative actions of 7-substituted 1,3-dihydroxyacridones; possible involvement of DNA topoisomerase II and protein kinase C as biochemical targets. Biorg. Med. Chem. 2:1994;1402-1411.
4. Bastow, K.F., Akanitapichat, P., 1977. Antiviral agents, DNA. In: Wolf, M.E. (Ed.), Burger's Medicinal Chemistry and Drug Discovery. Wiley, New York, pp. 497-549.
5. Chen M., Griffith B.P., Lucia H.L., Hsiung G.D. Efficacy of S62308 against guinea pig cytomegalovirus infection. Antimicrob. Agents. Chemother. 32:1988;678-683.
6. Elion G.B., Furman P.A., Fyfe J.A., De Miranda P., Beauchamp L., Schaeffer H.J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Nat. Acad. Sci. USA. 74:1977;5716-5720.
7. Fujiwara M., Okamoto M., Okamoto M., Watanabe M., Machida H., Shigeta S., Konno K., Yokuta T., Baba M. Acridone derivatives are selective inhibitors of HIV-1 replication in chronically infected cells. Antiviral Res. 43:1999;189-199.
8. Furman P.A., St. Clair M.H., Fyfe J.A., Rideout J.L., Keller P.M., Elion G.B. Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxymethoxymethyl)guanine and its triphosphate. J. Virol. 32:1979;72-77.
9. Helgestrand E., Eriksson B., Johansson N.G., Lannero B., Larson A., Misiorny A., Noren J.O., Sjoberg B., Stenberg K., Stening G., Stridh S., Oberg B., Alenius S., Philipson L. Trisodium phosphonoformate, a new antiviral compound. Science. 201:1978;819-821.
10. Honess R.W., Roizman B. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:1974;8-19.
11. Huang, E.-S., Kowalik, T.F., 1993. Diagnosis of human cytomegalovirus infection: laboratory approaches. In: Becker, X.Y., Daria, G., Huang, E.-S. (Eds.), Molecular Aspects of Human Cytomegalovirus Diseases, Springer, Berlin, pp. 225-255.
12. Hughes, G.K., Richie, J. 1951. Aust. J. Sci. Res. 423-431.
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
14. Lowden, C.T., 1995. Synthesis and biological evaluation of 1,3-dihydroxyacridones: inhibition of cell growth and mammalian topoisomerase II. Master's Thesis, UNC-Chapel Hill.
15. Lowden, C.T., 2002. Antiviral acridones. Ph.D. Thesis, UNC-Chapel Hill.
16. Martinez A., Gil C., Abasolo M.I., Castro A., Bruno A.M., Perez C., Prieto C., Otero J. Benzothiadiazine dioxide dibenzyl derivatives as potent human cytomegalovirus inhibitors: synthesis and comparative molecular field analysis. J. Med. Chem. 43:2000;3218-3225.
17. Smolders R.R., Hanuise J., Voglet N. Synthesis of some hydroxylated 9-acridanones. Bull. Soc. Chim. Belg. 93:1984;239-240.
18. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anti-cancer drug screening. J. Natl. Cancer. Inst. 82:1990;1107-1112.
19. Takemura Y., Ju-ichi M., Ito C., Furokawa H., Tokuda H. Studies on the inhibitory effects of some acridone alkaloids on Epstein-Barr virus activation. Planta. Med. 61:1995;366-367.
20. Taraporewala I.B., Cessac J.W., Chanh T.C., Delgado A.V., Schinazi R.F. HIV-1 neutralization and tumor cell proliferation inhibition in vitro by simplified analogues of pyrido[4,3,2-mn]thiazolo[5,4-b]acridine marine alkaloids. J. Med. Chem. 35:1992;2744-2752.
21. Vance J.R., Bastow K.F. Inhibition of DNA topoisomerase II catalytic activity by the antiviral agents 7-chloro, 1,3-dihydroxyacridone and 1,3,7-trihydroxyacridone. Biochem. Pharmacol. 58:1999;703-708.
22. Yamamoto N., Furukawa H., Ito Y., Yoshida S., Maneo K., Nishiyama Y. Anti-herpesvirus activity of citrusinine-I, a new acridone alkaloid, and related compounds. Antiviral Res. 12:1989;21-36.
23. Zarubaev, V.V., Slita, A.V., Krivitskaya, V.Z., Sirotkin, A.K., Kovalenko, A.L., Chatterjee, N.K., 2003. Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Res., Available online 7 January 2003. p. 33.
24. Zhou R., Drach J.C., Townsend L.B. Design, synthesis and antiviral evaluation of 2-substituted 4,5-dichloro- and 4,6-dichloro-1-β-D-ribofuranosyl benzimidazoles as potential agents for human cytomegalovirus infections. J. Med. Chem. 40:1997;802-810.